Mixed review for Biotronik's absorbable stent

Biotronik touted positive early findings from a 1st-in-man trial of its absorbable metal stent, but researchers say the device need isn't as efficient as it could be.

German medical device maker Biotronik [1] touted early findings from a 1st-in-man study of its Dreams absorbable drug-eluting stent, with researchers reporting a mixed bag of findings for the device.

The Dreams stent proved safe at 1 year following the procedure, but wasn't up to par with some rival devices, researchers noted.